Medivolve Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CAD 86.82 million compared to CAD 10.58 million a year ago. Net loss was CAD 6.61 million compared to CAD 37.78 million a year ago.

Basic loss per share from continuing operations was CAD 0.3 compared to CAD 5.7 a year ago. Diluted loss per share from continuing operations was CAD 0.3 compared to CAD 5.7 a year ago.